Should GLP-1 receptor agonist therapy be used to treat obesity in Bardet-Biedl syndrome? Tomlinson JW. J Clin Invest 2025;135:e191822.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tomlinson JW. Should GLP-1 receptor agonist therapy be used to treat obesity in Bardet-Biedl syndrome? J Clin Invest 2025;135:e191822.
PMID: 40519161